Efficacy of a leading drug against MERS-CoV infection in vivo

Project: Other project

Project Details

StatusActive
Effective start/end date3/1/20 → 2/28/21

Funding

  • Adamis Pharmaceuticals Corporation: $25,000.00
View all
View less